Assignee
VITAE PHARMACEUTICALS LLC
US·15 granted patents·8 pending applications·48 citations·filing 2016–2025
Top patents by PatentIndex Score
23 records- 0195US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0293US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0391US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 0491US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 0588US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 0688US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 0787US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 0886US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 0985US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 1082US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 1179US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 1278US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 1377US10829481B2Benzimidazole derivatives as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Nov 10, 2020·1 cites·22 claims
- 1476US10913739B2Inhibitors of RORγVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Feb 9, 2021·1 cites·6 claims
- 1575US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1672US11008340B2Modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 18, 2021·1 cites·14 claims
- 1767US2021300869A1Modulators of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 1865US2020138812A1Liver x receptor modulatorsVITAE PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 1962US11186573B2Inhibitors of ROR gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Nov 30, 2021·0 cites·6 claims
- 2062US2021094940A1Modulators of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2161US2020339566A1Dihydropyrrolopyridine inhibitors of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2260US2021230158A1INHIBITORS OF RORgammaVITAE PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2356US2022112190A1Inhibitors of ror gammaVITAE PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VITAE PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →